Hot Features
プレミアム
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
期間:
書込みモード:
| 出来高 | 486,753 |
|
|||||
| ニュース | - | ||||||
| 今日の高値 | 46.59 | 安値 高値 |
|||||
| 今日の安値 | 44.66 | ||||||
| 名称 | 銘柄コード | 市場 | 種別 |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | CRNX | NASDAQ | 普通株式 |
| 前日比 | 前日比 % | 現在値 | 時刻
|
|
|---|---|---|---|---|
| -1.13 | -2.47% | 44.71 | 09:00:00 |
| 始値 | 安値 | 高値 | 終値 | 前日終値 |
|---|---|---|---|---|
| 45.40 | 44.66 | 46.59 | 44.71 | 45.84 |
| 取引数 | 出来高 | VWAP | Financial Volume | 平均音量 | 52 Week Range |
|---|---|---|---|---|---|
| 11,072 | 486,753 | US$ 45.38 | US$ 22,091,079 | - | 15.76 - 53.70 |
| 最終取引 | タイプ | 数量 | 価格 | 通貨 |
|---|---|---|---|---|
| 07:23:04 | 10 | US$ 44.70 | USD |
企業情報 - Crinetics Pharmaceuticals Inc
| 時価総額 | 発行済株式数 | Float | 歳入 | 利益/損失 | 一株当たり利益 | PER |
|---|---|---|---|---|---|---|
| 3.11B | 69.60M | - | 4.01M | -214.53M | -3.08 | - |
| Short Interest | 1株あたり配当 | 配当利回り | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ニュース - Crinetics Pharmaceuticals
| 日付 | 時間 | 情報元 | タイトル |
|---|---|---|---|
| 2024/6/04 | 05:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2024/5/31 | 05:28 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/5/29 | 02:44 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
| 2024/5/22 | 21:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2024/5/15 | 07:29 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/5/11 | 05:57 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/5/11 | 01:40 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
| 2024/5/10 | 05:38 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2024/5/10 | 05:12 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2024/5/09 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2024/5/09 | 05:19 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
| 2024/3/12 | 05:15 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
チャート - Crinetics Pharmaceuticals
| 期間 † | 始値 | 高値 | 安値 | VWAP | 平均出来高 | 前日比 | % |
|---|---|---|---|---|---|---|---|
| 1週 | 45.69 | 48.71 | 44.08 | 46.28 | 1,090,798 | -0.98 | -2.14% |
| 1ヶ月 | 49.43 | 53.70 | 44.08 | 48.32 | 1,000,466 | -4.72 | -9.55% |
| 3ヶ月 | 37.96 | 53.70 | 37.52 | 46.38 | 939,879 | 6.75 | 17.78% |
| 6ヶ月 | 33.23 | 53.70 | 32.555 | 41.97 | 854,036 | 11.48 | 34.55% |
| 1年 | 22.11 | 53.70 | 15.76 | 33.18 | 949,909 | 22.60 | 102.22% |
| 3年 | 17.00 | 53.70 | 15.23 | 28.03 | 526,325 | 27.71 | 163.00% |
| 5年 | 27.75 | 53.70 | 10.63 | 26.56 | 361,850 | 16.96 | 61.12% |
